Your browser doesn't support javascript.
loading
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid.
Lin, Bin; Hu, Yangmin; Xu, Ping; Xu, Tao; Chen, Chunyan; He, Le; Zhou, Mi; Chen, Zhangzhang; Zhang, Chunhong; Yu, Xuben; Fang, Luo; Zhu, Junfeng; Ji, Yanlan; Lin, Qun; Cao, Hengbin; Dai, Youqin; Lu, Xiaoyan; Shi, Changcheng; Li, Li; Wang, Changjiang; Li, Xumei; Fang, Qiongyan; Miao, Jing; Zhu, Zhengyi; Lin, Guangyong; Zhan, Haichao; Lv, Shiwen; Zhu, Yalan; Cai, Xinjun; Ying, Yin; Chen, Meng; Xu, Qiong; Zhang, Yiwen; Xu, Yubin; Federico, Pea; Jiang, Saiping; Dai, Haibin.
Afiliación
  • Lin B; Department of Pharmacy, Changxing People's Hospital, Changxing Branch, Second Affiliated Hospital of Zhejiang University School of Medicine, Huzhou, China.
  • Hu Y; Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou, Huzhou, China.
  • Xu P; Department of Pharmacy, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Xu T; Department of Pharmacy, Ningbo First Hospital, Ningbo, China.
  • Chen C; Department of Pharmacy, Ningbo First Hospital, Ningbo, China.
  • He L; Department of Pharmacy, Ningbo First Hospital, Ningbo, China.
  • Zhou M; Department of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen Z; Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, China.
  • Zhang C; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yu X; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Fang L; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhu J; Department of Pharmacy, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Ji Y; Department of Pharmacy, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Lin Q; Department of Pharmacy, Deqing People's Hospital, Huzhou, China.
  • Cao H; Department of Pharmacy, Tiantai People's Hospital, Taizhou, China.
  • Dai Y; Department of Clinical Pharmacy, Huzhou Central Hospital, Huzhou, China.
  • Lu X; Department of Pharmacy, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
  • Shi C; Department of Pharmacy, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
  • Li L; Department of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wang C; Department of Pharmacy, Zhejiang Hospital, Hangzhou, China.
  • Li X; Department of Pharmacy, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Fang Q; Department of Pharmacy, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Miao J; Department of Pharmacy, Zhoushan Hospital, Zhoushan, China.
  • Zhu Z; Department of Pharmacy, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Lin G; Department of Pharmacy, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Zhan H; Department of Pharmacy, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Lv S; Department of Clinical Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
  • Zhu Y; Department of Clinical Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
  • Cai X; Department of Clinical Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
  • Ying Y; Department of Pharmacy, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Chen M; Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou, China.
  • Xu Q; Department of Pharmacy, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Zhang Y; Department of Pharmacy, Putuo Hospital, Zhoushan, China.
  • Xu Y; Clinical Pharmacy Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Federico P; Department of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
  • Jiang S; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Dai H; SSD Clinical Pharmacology, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Front Public Health ; 10: 967311, 2022.
Article en En | MEDLINE | ID: mdl-36033811
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Oxazolidinonas Límite: Humans Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Oxazolidinonas Límite: Humans Idioma: En Revista: Front Public Health Año: 2022 Tipo del documento: Article País de afiliación: China